4 insiders reported 31 Form 4 transactions for VYNE Therapeutics Inc. (VYNE) over the past 18 months (most recent 2026-07-24). Recent activity: Harsch Mutya (CHIEF LEGAL OFFICER AND GC) Sell 22,516 shares, Stuart Iain (CHIEF SCIENTIFIC OFFICER) Sell 15,405 shares, Domzalski David (PRESIDENT AND CEO) Sell 79,391 shares, Zeronda Tyler (CHIEF FINANCIAL OFFICER) Sell 22,516 shares, Domzalski David (PRESIDENT AND CEO) Sell 12,214 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-24 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 22,516 | $20,210 |
| 2026-07-24 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 15,405 | $13,828 |
| 2026-07-24 | Domzalski David | PRESIDENT AND CEO | Sell | 79,391 | $71,261 |
| 2026-07-24 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 22,516 | $20,210 |
| 2026-07-02 | Domzalski David | PRESIDENT AND CEO | Sell | 12,214 | $7,948 |
| 2026-07-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,464 | $2,254 |
| 2026-07-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 3,464 | $2,254 |
| 2026-07-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,370 | $1,542 |
| 2026-06-02 | Domzalski David | PRESIDENT AND CEO | Buy | 30,791 | $9,545 |
| 2026-04-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 4,007 | $2,394 |
| 2026-04-02 | Domzalski David | PRESIDENT AND CEO | Sell | 14,232 | $8,504 |
| 2026-04-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 4,007 | $2,394 |
| 2026-04-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,876 | $1,718 |
| 2026-01-05 | Domzalski David | PRESIDENT AND CEO | Sell | 12,684 | $7,357 |
| 2026-01-05 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,448 | $1,420 |
| 2026-01-05 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,579 | $2,076 |
| 2026-01-05 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 7,858 | $4,558 |
| 2025-10-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,453 | $834 |
| 2025-10-02 | Domzalski David | PRESIDENT AND CEO | Sell | 12,676 | $4,310 |
| 2025-10-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,581 | $1,218 |
| 2025-10-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 3,420 | $1,163 |
| 2025-07-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,581 | $5,909 |
| 2025-07-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,453 | $4,047 |
| 2025-07-02 | Domzalski David | PRESIDENT AND CEO | Sell | 12,676 | $20,915 |
| 2025-07-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 3,420 | $5,643 |
Source: SEC Form 4 filings · as of 2026-07-24